Research Article: Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
Abstract:
Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide and is characterized by high incidence, poor prognosis, and high mortality. Hepatocellular carcinoma is the most common type of liver cancer. Most patients with hepatocellular carcinoma have progressed to intermediate and advanced stages by the time they are diagnosed, missing the best time to receive surgical treatment, while the one-year survival rate of untreated patients with intermediate and advanced HCC is only .%. With the improvement in HCC treatment, various treatment options such as liver transplantation, surgical resection, systemic therapy, and liver-targeted therapy have become available. However, surgical treatment is still considered the primary treatment modality for hepatocellular carcinoma. However, the high tumor recurrence rate is the leading cause of postoperative death in patients with HCC, and the -year recurrence rate can be as high as %-%.
Introduction:
Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide and is characterized by high incidence, poor prognosis, and high mortality. Hepatocellular carcinoma is the most common type of liver cancer. Most patients with hepatocellular carcinoma have progressed to intermediate and advanced stages by the time they are diagnosed, missing the best time to receive surgical treatment, while the one-year survival rate of untreated patients with intermediate and advanced HCC is only .%. With the…
Read more